icad inc. (ICAD) Social Stream
Featured Post From StockTwits About ICAD
$ICAD iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical AdoptionQuantisnow, published January 21, 2021
🐃Bullish or 🐻Bearish? Read and Vote!